ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet

RxCUI
1373502
RxNorm name
ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet
Display name
Ethinyl estradiol/Levonorgestrel (Oral Pill)
Full name
ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet
Term type
SCD
Status
Active
Strength
0.025-0.15 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-16 14:56:59

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
052013
Active start
052013
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
ethinyl estradiol0.025 MG / 1 EACHethinyl estradiolethinyl estradiol
levonorgestrel0.15 MG / 1 EACHlevonorgestrellevonorgestrel

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ethinyl estradiol4124
levonorgestrel6373

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet1NAMES
RxNorm Nameethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID
3 linked values
3CODES
RxCUI13735021CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RosyrahLEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLXiromed, LLCd2f0af55-205f-df9c-c572-1f7b149766552025-11-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1373502
RivelsaLEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLTeva Pharmaceuticals USA, Inc.822e56c6-562f-4299-bf4f-eaee0c0f2b7a2024-10-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1373502
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLLEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLMylan Pharmaceuticals Inc.5c1d0a3a-1b24-44a0-9c53-224365b659452023-05-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1373502

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
822e56c6-562f-4299-bf4f-eaee0c0f2b7aethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet [PSN] · ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet [SCD]213These highlights do not include all the information needed to use RIVELSA safely and effectively. See full prescribing information for RIVELSA. RIVELSA ® (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 198220241022
5c1d0a3a-1b24-44a0-9c53-224365b65945ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet [PSN] · ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet [SCD]27These highlights do not include all the information needed to use LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS, safely and effectively. See full prescribing information for LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS. LEVONORGESTREL and ETHINYL ESTRADIOL tablets, and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 198220230531
d2f0af55-205f-df9c-c572-1f7b14976655ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet [PSN] · ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use ROSYRAH, safely and effectively. See full prescribing information for ROSYRAH. ROSYRAH, for oral use Initial U.S. Approval: 198220251110

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCG03ADEmergency contraceptivesATC1-4levonorgestrel
ATCL02AAEstrogensATC1-4ethinyl estradiol
ATCG03CANatural and semisynthetic estrogens, plainATC1-4ethinyl estradiol
ATCG03ACProgestogensATC1-4levonorgestrel
ATCG03AAProgestogens and estrogens, fixed combinationsATC1-4ethinyl estradiol / levonorgestrel
ATCG03ABProgestogens and estrogens, sequential preparationsATC1-4ethinyl estradiol / levonorgestrel
FDASPLD045167Progesterone CongenersCHEMhas_chemical_structurelevonorgestrel
FDASPLN0000175825EstrogenEPChas_epcethinyl estradiol
FDASPLN0000175602ProgestinEPChas_epclevonorgestrel
FDASPLN0000175832Progestin-containing Intrauterine SystemEPChas_epclevonorgestrel
FDASPLN0000000100Estrogen Receptor AgonistsMOAhas_moaethinyl estradiol
FDASPLN0000175830Inhibit Ovum FertilizationPEhas_pelevonorgestrel
MEDRTD004997Ethinyl EstradiolCHEMhas_ingredientethinyl estradiol
MEDRTD016912LevonorgestrelCHEMhas_ingredientlevonorgestrel
MEDRTD000022Abortion, SpontaneousDISEASEinduceslevonorgestrel
MEDRTD018248Adenoma, Liver CellDISEASEci_withlevonorgestrel
MEDRTD001943Breast NeoplasmsDISEASEci_withethinyl estradiol
MEDRTD001943Breast NeoplasmsDISEASEmay_treatethinyl estradiol
MEDRTD001943Breast NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD002539Cerebral Arterial DiseasesDISEASEci_withethinyl estradiol
MEDRTD002561Cerebrovascular DisordersDISEASEci_withlevonorgestrel
MEDRTD003324Coronary Artery DiseaseDISEASEci_withethinyl estradiol
MEDRTD003327Coronary DiseaseDISEASEci_withlevonorgestrel
MEDRTD003920Diabetes MellitusDISEASEci_withlevonorgestrel
MEDRTD004342Drug HypersensitivityDISEASEci_withethinyl estradiol
MEDRTD004342Drug HypersensitivityDISEASEci_withlevonorgestrel
MEDRTD016889Endometrial NeoplasmsDISEASEci_withethinyl estradiol
MEDRTD016889Endometrial NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD020773Headache DisordersDISEASEci_withlevonorgestrel
MEDRTD006349Heart Valve DiseasesDISEASEci_withlevonorgestrel
MEDRTD019584Hot FlashesDISEASEmay_treatethinyl estradiol
MEDRTD006973HypertensionDISEASEci_withlevonorgestrel
MEDRTD006973HypertensionDISEASEci_withethinyl estradiol
MEDRTD007006HypogonadismDISEASEmay_treatethinyl estradiol
MEDRTD007565JaundiceDISEASEci_withlevonorgestrel
MEDRTD007674Kidney DiseasesDISEASEci_withlevonorgestrel
MEDRTD008107Liver DiseasesDISEASEci_withethinyl estradiol
MEDRTD008107Liver DiseasesDISEASEci_withlevonorgestrel
MEDRTD008113Liver NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD008594Menopause, PrematureDISEASEmay_treatethinyl estradiol
MEDRTD008595MenorrhagiaDISEASEmay_treatethinyl estradiol
MEDRTD009376Neoplasms, Hormone-DependentDISEASEci_withethinyl estradiol
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_preventethinyl estradiol
MEDRTD011247PregnancyDISEASEmay_preventethinyl estradiol
MEDRTD011247PregnancyDISEASEmay_preventlevonorgestrel
MEDRTD011247PregnancyDISEASEci_withlevonorgestrel
MEDRTD011247PregnancyDISEASEci_withethinyl estradiol
MEDRTD016649Primary Ovarian InsufficiencyDISEASEmay_treatethinyl estradiol
MEDRTD011471Prostatic NeoplasmsDISEASEmay_treatethinyl estradiol
MEDRTD013923ThromboembolismDISEASEci_withlevonorgestrel
MEDRTD013923ThromboembolismDISEASEci_withethinyl estradiol
MEDRTD013924ThrombophlebitisDISEASEci_withethinyl estradiol
MEDRTD013924ThrombophlebitisDISEASEci_withlevonorgestrel
MEDRTD064424Tobacco UseDISEASEci_withethinyl estradiol
MEDRTD014029Tobacco Use DisorderDISEASEci_withlevonorgestrel
MEDRTD014592Uterine HemorrhageDISEASEci_withlevonorgestrel
MEDRTN0000000100Estrogen Receptor AgonistsMOAhas_moaethinyl estradiol
MEDRTN0000000185Progestational Hormone Receptor AgonistsMOAhas_moalevonorgestrel
MEDRTN0000008311Bone Formation StimulationPEhas_peethinyl estradiol
MEDRTN0000008595Decreased Embryonic ImplantationPEhas_peethinyl estradiol
MEDRTN0000008595Decreased Embryonic ImplantationPEhas_pelevonorgestrel
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_pelevonorgestrel
MEDRTN0000178478Increased Blood PressurePEci_pelevonorgestrel
MEDRTN0000009717Inhibit OvulationPEhas_peethinyl estradiol
MEDRTN0000009717Inhibit OvulationPEhas_pelevonorgestrel
MEDRTN0000009902Vaginal Function AlterationPEhas_peethinyl estradiol
MEDRTN0000008289Aromatic hydroxylationPKhas_pkethinyl estradiol
MEDRTN0000000045Fecal ExcretionPKhas_pkethinyl estradiol
MEDRTN0000000026Hepatic MetabolismPKhas_pkethinyl estradiol
MEDRTN0000000042Renal ExcretionPKhas_pkethinyl estradiol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.025 MG / 0.15 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESANDAANDA206053
NAMESPrescribable Synonymethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet
SOURCESSourceMetathesaurus FDA Structured Product Labels